COMPUGEN LTD (CGEN) awards RSUs and stock options to director Halevy Gilead

Rhea-AI Filing Summary

COMPUGEN LTD director Halevy Gilead received new equity awards on July 29, 2026. The grants consist of 7,500 restricted stock units and a share option for 10,000 ordinary shares at an exercise price of $2.26 per share, expiring July 29, 2036. Both the RSUs and the option vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments, subject to continued service. After these awards, Gilead directly holds 18,907 ordinary shares and options for 10,000 shares.

Insider Trade Summary

Net Buyer: 7,500 shares

Net Buy 2 txns

Insider Halevy Gilead

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Share Option (right to buy) F2	10,000	$0.00	$0.00
Grant/Award	Ordinary Shares F1	7,500	$0.00	$0.00

Holdings After Transaction: Share Option (right to buy) — 10,000 shares (Direct); Ordinary Shares — 18,907 shares (Direct)

Footnotes (2)

1. F1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.
2. F2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

Key Figures

RSU award size: 7,500 shares Option grant size: 10,000 shares Option exercise price: $2.26 per share +3 more

6 metrics

RSU award size 7,500 shares Restricted stock units granted to Halevy Gilead on July 29, 2026

Option grant size 10,000 shares Share option (right to buy) granted on July 29, 2026

Option exercise price $2.26 per share Exercise price for 10,000-share option grant

Option expiration date 2036-07-29 Expiration of the 10,000-share option grant

Initial vesting date 2027-10-01 25% of both RSUs and options vest on this date

Post-transaction share holdings 18,907 shares Ordinary shares directly held by Halevy Gilead after awards

Key Terms

restricted stock unit, Share Option (right to buy, vesting, Ordinary Shares

4 terms

restricted stock unit financial

"Represents a restricted stock unit ("RSU") award."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

Share Option (right to buy financial

"security_title": "Share Option (right to buy)""

vesting financial

"The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Ordinary Shares financial

"underlying_security_title": "Ordinary Shares""

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 04:03 PM Accepted by SEC EDGAR 07/30/2026 - 04:03 PM Learn about SEC filing dates

FAQ

What equity awards did COMPUGEN LTD (CGEN) director Halevy Gilead receive on July 29, 2026?

Halevy Gilead received 7,500 restricted stock units and a share option for 10,000 ordinary shares at an exercise price of $2.26 per share. These awards increase his direct holdings and align compensation with future company performance through multi-year vesting.

How do the new RSUs granted to COMPUGEN LTD (CGEN) director Halevy Gilead vest?

The 7,500 RSUs vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments. Vesting is conditioned on Halevy Gilead’s continued service to the company throughout the vesting period.

What are the key terms of Halevy Gilead’s new stock options at COMPUGEN LTD (CGEN)?

The option covers 10,000 ordinary shares with an exercise price of $2.26 per share and an expiration date of July 29, 2036. It vests 25% on October 1, 2027, and the balance in 12 equal quarterly installments, subject to continued service.

What are Halevy Gilead’s COMPUGEN LTD (CGEN) share holdings after the July 29, 2026 awards?

Following the transactions, Halevy Gilead directly holds 18,907 ordinary shares of COMPUGEN LTD and a stock option for 10,000 shares. These positions reflect only the reported holdings in this insider filing and exclude any unreported interests.

Are Halevy Gilead’s new COMPUGEN LTD (CGEN) equity awards immediately exercisable or vested?

No, both awards are subject to vesting. The RSUs and options each vest 25% on October 1, 2027, with the remaining 75% vesting in 12 equal quarterly installments, contingent on his continued service to COMPUGEN LTD.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Halevy Gilead

(Last) (First) (Middle)

C/O COMPUGEN LTD.

26 HAROKMIM STREET

(Street)

HOLON 5885849

(City) (State) (Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
COMPUGEN LTD [ CGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol
[CGEN]

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	07/29/2026		A		7,500(1)	A	$0	18,907	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share Option (right to buy)	$2.26	07/29/2026		A		10,000		(2)	07/29/2036	Ordinary Shares	10,000	$0	10,000	D

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs vest 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

2. This option vests 25% on October 1, 2027, and the remainder vests in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service to the Issuer.

	/s/ Gilead Halevy	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)